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Abstract
Background: The risk of experiencing an acute myocardial infarction (AMI) increases with age and Canada’s
population is aging. The objective of this analysis was to examine trends in the AMI hospitalization rate in Canada
between 2002 and 2009 and to estimate the potential increase in the number of AMI hospitalizations over the
next decade.
Methods: Aggregated data on annual AMI hospitalizations were obtained from the Canadian Institute for Health
Information for all provinces and territories, except Quebec, for 2002/03 and 2009/10. Using these data in a Poisson
regression model to control for age, gender and year, the rate of AMI hospitalizations was extrapolated between
2010 and 2020. The extrapolated rate and Statistics Canada population projections were used to estimate the
number of AMI hospitalizations in 2020.
Results: The rates of AMI hospitalizations by gender and age group showed a decrease between 2002 and 2009 in
patients aged ≥ 65 years and relatively stable rates in those aged < 64 years in both males and females. However,
the total number of AMI hospitalizations in Canada (excluding Quebec) is projected to increase by 4667 from
51847 in 2009 to 56514 in 2020, a 9.0% increase. Inflating this number to account for the unavailable Quebec data
results in an increase of approximately 6200 for the whole of Canada. This would amount to an additional cost of
between $46 and $54 million and sensitivity analyses indicate that it could be between $36 and $65 million.
Conclusions: Despite projected decreasing or stable rates of AMI hospitalization, the number of hospitalizations is
expected to increase substantially as a result of the aging of the Canadian population. The cost of these
hospitalizations will be substantial. An increase of this extent in the number of AMI hospitalizations and the
ensuing costs would significantly impact the already over-stretched Canadian healthcare system.
Background
Despite therapeutic advances in the treatment of acute
myocardial infarction (AMI) over the past two decades,
the condition continues to be a leading cause of death
in older adults in developed countries. Since the risk of
experiencing an AMI increases with age [1], changes in
the occurrence of this disorder have a major impact on
the overall health of a country’s population and its
healthcare system.
In Canada, the population is aging and the country is
particularly impacted by the baby boom generation.
Baby boomers constitute almost one-third of the Cana-
dian population, a larger proportion than in the other
three countries (Australia, New Zealand and the United
States) that experienced the baby boom effect. From
2008 onward, the leading edge of the boomer generation
(those born between 1947 and 1966 [2]) moved into
their 60s, while its youngest members edged into their
40s. Aging baby boomers have the potential to stretch
an already over-extended healthcare system over the
next few decades.
In addition to the aging population, there is an unpre-
cedented and growing number of young Canadian adults
who are overweight or obese [3], women are entering
their adult years with a higher risk for heart disease [4]
and some of Canada’s fastest growing ethno-cultural
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factors for cardiovascular disease [5,6]. All these factors
could potentially overwhelm the healthcare system with
an entire new generation of patients [7].
The objective of this analysis was to examine trends in
the hospitalization rate for AMI in Canada between
2002 and 2009 and to estimate the potential increase in
the number of hospitalizations for AMI over the next
decade.
Methods
Aggregated data on annual hospitalizations with a most
responsible (principal) diagnosis of AMI using Interna-
tional Classification of Diseases (ICD) codes (ICD-9 410
and ICD-10-CA I21 and I22) were obtained from the
Discharge Abstract Database and Hospital Morbidity
Database of the Canadian Institute for Health Informa-
tion (CIHI) for nine of Canada’s1 0p r o v i n c e sa n da l l
three of its territories for the fiscal years 2002/03 to
2009/10 inclusive [8]. The CIHI data record hospitaliza-
tions only and it is not possible to link hospitalizations
for individual patients so that we could not link a re-
admission for the same AMI episode or a new AMI
with a previous one in the same patient. Information
was only available for 2002/03-2009/10 and, since data
from Quebec were unavailable for most of the time per-
iod, Quebec was excluded from the analysis.
The CIHI data were categorized into 10 age groups
starting at < 45 years (since this is the age at which the
risk of an AMI begins to increase) and ending at ≥ 85
years and these were re-grouped into four categories (<
50, 50-64, 65-74 and ≥ 75 years) for consistency with
previous analyses [1,9,10]. Data were also obtained on
the two most relevant revascularization procedures (per-
cutaneous coronary intervention [PCI] and/or coronary
artery bypass graft [CABG]) and the length of stay
(LOS), categorized as 1-3 days, 4-6 days, 7-11 days or
12 + days by CIHI, associated with each hospitalization.
The mean LOS for each gender/age group in each year
was estimated using the midpoint of each of the first
three categories and 14 days for the final one.
Using provincial and territorial mid-year population
estimates obtained from Statistics Canada, annual rates
of AMI hospitalization and associated rates of revascu-
larization procedures were estimated for the four age
groups stratified by gender. The rates were calculated by
dividing the number of hospitalizations for each age-
gender category by the corresponding population esti-
mate and age and gender standardized to the 2002
population.
The annual rates of AMI hospitalization for 2002 to
2009 were analyzed using a log-linear Poisson regression
model to control for age (four categories), gender and
fiscal year (as a continuous variable ranging between
zero and seven). The use of four age groups led to a lar-
ger number of hospitalization events within each age
category and, subsequently, to a more parsimonious and
stable model. Two-way interaction terms between age
category, gender and fiscal year were also considered in
the Poisson model to increase its flexibility. The annual
population estimate in each age-gender category (eight
in total) was included as an offset term to account for
different size of the population at risk. The models were
fitted on 64 observed data points (four age groups X
two genders X eight years) using a quasi-likelihood
approach to account for over-dispersion. The unit of
analysis can be considered as person-year assuming all
eight age-gender groups were at risk of being hospita-
lized for AMI throughout a year. An over-dispersion
parameter, estimated by dividing the square root of the
Pearson c
2 v a l u eb yt h er e s i d u a ld e g r e e so ff r e e d o m ,
was introduced to reflect the greater variability in the
observed data than expected from the Poisson distribu-
tion [11,12]. The model goodness-of-fit was examined
using the deviance and Pearson c
2 values. Final model
selection was based on change in the Akaike informa-
tion criterion, a measure of the relative goodness of fit
of a statistical model, and the Bayesian information
criterion.
The regression model was used to estimate the rate of
AMI hospitalizations between 2010 and 2020. Statistics
Canada has projected the national and provincial popu-
lations to 2036 based on the 2009 population and a ser-
ies of assumptions which are “summarized into a few
scenarios that are intended to be both plausible and
relevant” so that they “offer a range of possibilities as to
how the Canadian population will evolve in the
future”[13]. The projections are produced by means of a
micro-simulation method using a number of variables
that reflect the ethno-cultural diversity of the Canadian
population, with the basic geographic level being coun-
try’s 33 census metropolitan areas. The projections are
intended for a wide range of users including the federal
government, provincial, territorial or municipal govern-
ments, research groups, academics, interest groups,
international and non-governmental organizations, edu-
cational institutions and the general public.
The projections are based on six scenarios (Table 1)
that use varying estimates of fertility, life expectancy,
immigration and interprovincial migration. The most
important of these is the first medium growth scenario
(number 2 in Table 1), which Statistics Canada generally
uses in its own analyses. In previous projections, the
medium scenario has been found to be close to reality
[13]. Using the population projections of scenario 2 and
the AMI rate estimates, annual absolute numbers of
AMI hospitalizations for the eight age-gender categories
between 2010 and 2020 were estimated. Population
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narios (numbers 1 and 6 in Table 1) were used as a sen-
sitivity assessment.
Data from CIHI on estimates of the average cost of an
AMI without and with a cardiac catheter in Canada [14]
were used to estimate the impact of projected changes
in the number of AMI hospitalizations.
The data on PCI and CABG were examined to assess
what percentage of the hospitalizations included these
procedures. Similarly, trends in LOS were reviewed.
Results
The rates of AMI hospitalizations by gender and age
g r o u pa r es h o w ni nF i g u r e1 aa n d1 b .I ng e n e r a l ,t h e
rates show a decrease between 2002 and 2009 in the
two oldest age groups (65-74 and ≥ 75 years) and a
modest increase in the younger age groups (< 50 and
50-64 years) in both sexes.
The final Poisson regression model contained three
main effects (age, gender and year) and three two-way
interactions between the main effects (Appendix). This
reflected the observed difference in the rate of AMI hos-
pitalization between eight age by gender groups at base-
line (year 2002) and allowed year to have different effects
on the AMI rate among the groups. Using the Poisson
regression model, the projections of the rates between
2010 and 2020 show stable estimates of the rate of AMI
hospitalization in males and females aged < 65 years and
decreasing rates in patients aged ≥ 65 years (Figure 1a
and 1b), although the model was a better fit in females
than males.
The estimated rates, together with the population pro-
jections from Statistics Canada, were used to project the
number of AMI hospitalizations in Canada (excluding
Quebec) to 2020. Table 2 shows the observed and pre-
dicted absolute numbers of AMI hospitalizations for
males and females in 2009 and the projected numbers for
2020 for the low, medium and high Statistics Canada sce-
narios. Under the medium scenario, although AMI hospi-
talizations in the oldest age group are anticipated to
decrease, the total number of AMI hospitalizations in
Canada (excluding Quebec) is projected to increase by
4667 from 51847 in 2009 to 56514 in 2020, a 9.0%
increase. The projected numbers under the low and high
scenarios are 55538 and 57497, respectively, which repre-
sent increases of 3691 (7.1%) and 5650 (10.9%).
The estimated mean LOSs between 2002 and 2009 for
males and females combined in each age group and each
year are shown in Figure 2. The genders were combined
because there was little difference between them, although
the LOS for females was always slightly greater than that
for males. The mean LOS declined in each age group by
17-33%, with decreases of 1.8, 2.1, 1.9 and 1.3 days in
patients aged < 50, 50-64, 65-74 and ≥ 75 years,
respectively.
The percentage of AMI hospitalizations with a PCI in
Canada (excluding Quebec) increased between 2002 and
2009 in both males and females in each age group
(Figure 3a and 3b). The increase was greatest in patients
aged ≥ 75 years (three-fold), compared with approxi-
mately a two-fold increase in the other age groups. In
contrast, the percentage of AMI hospitalizations with a
CABG decreased in the eight-year period by more than
half in both males and females from 2.5% and 1.3%,
respectively, in 2002 to 0.9% and 0.5% in 2009 (Figure 4a
and 4b).
Discussion
Hospital discharge abstract databases are increasingly
being used in health services research. AMI diagnostic
codes in Canadian administrative databases have been
validated using the hospital discharge data and chart
audits [15-18]. For example, Austin et al. found a sensi-
tivity of 89% and a specificity of 93% for patients
admitted to coronary care units [17]. Administrative
data have been used in surveillance of cardiovascular
surveillance [1,9,10,19-21] and other conditions [22]
with success.
The decreasing hospitalization rate for AMI in Canada
has been described by others previously. In particular, in
2009, Tu and his colleagues reported a substantial decrease
in hospitalization rates (standardized to the 1991 popula-
tion) for AMI and other cardiovascular disorders from
1994 to 2004 using CIHI data for the whole of Canada [1].
Our study resulted in a rate for 2004 are quite similar to
that of Tu et al., despite not having data for Quebec.
Similarly, the increasing use of PCI and the declining
use of CABG in AMI patients have also been previously
Table 1 The six scenarios used by Statistics Canada for population projection [13]
Scenario Fertility Life expectancy Immigration Interprovincial migration
1 Low growth Low Low Low Historical trends (1981-2008)
2 Medium growth, historical trends (1981 to 2008) Medium Medium Medium Historical trends (1981-2008)
3 Medium growth, trends 2006 to 2008 Medium Medium Medium 2006 to 2008 trends
4 Medium growth, trends 1988 to 1996 Medium Medium Medium 1988 to 1996 trends
5 Medium growth, trends 2001 to 2006 Medium Medium Medium 2001 to 2006 trends
6 High growth High High High Historical trends (1981-2008)
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2004-06, the rate of PCI use per 100,000 population in
Ontario rose by 20%, while the rate of CABG use fell by
10% [23]. In the CIHI data, the rate of PCI in Canada
(excluding Quebec) increased between 2002 and 2009
by 125% and the rate of CABG declined by over 60%.
Thus, there has been a significant change in the type of
care (PCI v. CABG) over recent years in Canada with
Figure 1 a Actual and projected rate of AMI hospitalization in Canadian males by age group, 2002-2020. AMI: Acute myocardial
infarction. b Actual and projected rate of AMI hospitalization in Canadian females by age group, 2002-2020. AMI: Acute myocardial infarction.
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Page 4 of 10PCI, which has been described as having a direct impact
on patient survival. PCI remains a central therapy for
patients with symptomatic coronary artery disease, parti-
cularly those with AMI, and has generated tremendous
attention in the last decade with issues such as the risks
and benefits of drug-eluting stents and anti-thrombotic
therapies [24]. There are few representative data
describing the contemporary patterns of care and out-
come trends in patient with AMI and/or undergoing
PCI. This is of particular importance because the pro-
cess of updating clinical practice guidelines and quality
metrics for AMI and PCI has accelerated.
The present analysis extends the previous work of Tu
et al. [1] to a more recent year (2009) and attempts to
project not only the rates, which our analysis suggests
will continue to decline in those aged ≥ 65 years and
remain relatively stable in those aged < 65 years, but
also the numbers of AMI hospitalizations to 2020.
Despite projected decreasing or stable rates of AMI hos-
pitalization, the number of hospitalizations is expected
to increase substantially as a result of the aging of the
Canadian population.
Our model indicates an increase in Canada (excluding
Quebec) of 4667 AMI hospitalizations by 2020, with a
Table 2 Observed and estimated absolute numbers of AMI hospitalizations in 2009 and 2020 for Canada (excluding
Quebec)
2009 2020 projections for 3 population scenarios*
Gender Age group Observed Estimated Low Medium High
N%
† N%
† N%
†
Male < 50 years 4739 4541 5412 14.2 5639 19.0 5863 23.7
50-64 years 12600 12053 14372 14.1 14528 15.3 14689 16.6
65-74 years 7413 7073 9057 22.2 9167 23.7 9287 25.3
≥ 75 years 9444 9182 8730 -7.6 8923 -5.5 9133 -3.3
All ages 34196 32849 37571 9.9 38257 11.9 38972 14.0
Female < 50 years 1102 1010 1307 18.6 1364 23.8 1421 28.9
50-64 years 3988 3758 4425 11.0 4468 12.0 4511 13.1
65-74 years 3531 3593 4536 28.5 4579 29.7 4618 30.8
≥ 75 years 9030 8888 7699 -14.7 7846 -13.1 7875 -12.8
All ages 17651 17249 17967 1.8 18257 3.4 18525 5.0
Total 51847 50098 55538 7.1 56514 9.0 57497 10.9
AMI Acute myocardial infarction
* Using Statistics Canada population projections
† Percentage change over the 2009 observed figure
Figure 2 Estimated mean length of hospital stay for AMI by age group, 2002-2009. AMI: Acute myocardial infarction.
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approximately 25% of the Canadian population, which
suggests an increase of about 6200 for the whole of
Canada (sensitivity range, 4900 to 7500). Using the CIHI
estimate for the average cost of a myocardial infarction/
shock/arrest without cardiac catheter in Canada in
2008/09 of $7412 [14], the additional cost for this
increase in AMI hospitalizations would be approxi-
mately $46 million (sensitivity range, $36-$55 million).
If one assumes that the majority of AMI hospitalizations
(80%) will include a cardiac catheter for which the
average cost in Canada in 2008/09 was $8984 [14], the
additional cost for the projected increase in the number
of AMI hospitalizations to 2020 would be approximately
$54 million (sensitivity range, $42-$65 million). These
figures do not take account of economic inflation,
changes in AMI risk due to the epidemic in diabetes
and obesity, or the fact that seniors generally have a
longer LOS.
Attempting to incorporate changes in the use of PCI
or CABG and in LOS with the projected trend in AMI
hospitalizations was problematic. If one extrapolates the
Figure 3 a Percentage of AMI hospitalizations with a PCI in Canadian males by age group, 2002-2009. AMI: Acute myocardial infarction.
PCI: Percutaneous coronary intervention. b Percentage of AMI hospitalizations with a PCI in Canadian females by age group, 2002-2009. AMI:
Acute myocardial infarction, PCI: Percutaneous coronary intervention.
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with a PCI between 2002 and 2009, by 2020 almost all
AMI hospitalizations would have a PCI. Projecting the
proportion of AMI hospitalizations with a CABG would
suggest that almost no AMI hospitalizations in 2020
would have a CABG. These scenarios are unrealistic.
While the proportion of AMI hospitalizations with a
PCI are likely to continue to increase and the propor-
tion with a CABG may continue to decrease, it is antici-
pated that they will plateau at some point, but our data
do not allow us to estimate where this could be
expected to occur, although it seems likely that it will
be before 2020. Similarly, the trend of shortening
average LOS may continue for some years but even-
tually a minimum must be reached. Thus, we have not
provided projections for these variables.
Our analysis has limitations. The CIHI data record
only hospitalizations and not individual episodes of
patient care and it was not possible to include Quebec
in the analysis. The coding of hospitalizations changed
from ICD-9 to ICD-10 between 2001/02 and 2002/03 in
most provinces and territories but did not occur until
2003/04 in New Brunswick and 2004/05 in Manitoba.
The change in coding system included a reduction in
the eight-week period after an initial AMI hospitaliza-
tion in which readmission for AMI-related problems
Figure 4 a Percentage of AMI hospitalizations with a CABG in Canadian males by age group, 2002-2009.A M I :A c u t em y o c a r d i a l
infarction. CABG: Coronary artery bypass graft. b Percentage of AMI hospitalizations with a CABG in Canadian females by age group, 2002-2009.
AMI: Acute myocardial infarction. CABG: Coronary artery bypass graft.
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weeks in ICD-10. This change in coding does not
explain the decrease in 2006; we are unable to ascertain
a reason for this reduction, but it should be noted that,
if data from only 2002/03 to 2006/07 had been used, the
results of the projection in numbers of AMI hospitaliza-
tions would likely have been quite different. We consid-
ered it appropriate to use all the data available rather
than selectively use them. Fiscal year was used as a lin-
ear variable, which is a traditional approach, because it
was considered to be the most reliable based on the lim-
ited number of years available and the structure of the
data (Figures 1a and 1b).
As previously mentioned, the projection in AMI hos-
pitalization rates did not take account of the increasing
prevalence of diabetes and obesity in the Canadian
population (especially in young adults) or changes in
cardiovascular drug therapy, such as increasing use of
statins and anti-hypertensives. It also assumed that the
treatment of cardiovascular disease and AMI in particu-
lar will remain largely the same over the next 10 years,
although new clinical practices, in which physicians are
able to predict the prognosis for an AMI patient with
greater accuracy, could emerge that would lead to a
reduction in the likelihood of hospitalization for AMI or
the length of stay [25-27]. These limitations point to the
need for a more comprehensive and refined national
disease surveillance system in Canada with which more
in depth studies would be performed.
Conclusions
Despite continued efforts to prevent cardiovascular dis-
ease, which as evidenced by the declining rate of AMI
hospitalization in older Canadians, cardiovascular disease
continues to be the leading cause of death and reason for
hospital admissions. Moreover, there is little indication of
a radical change in cardiovascular therapy that will sub-
stantially reduce the risk of AMI, whereas it is clear that
the Canadian population is aging and the prevalence of
diabetes and obesity is increasing, which will significantly
impact the already over-stretched Canadian healthcare
system. Further advances in the prevention and treat-
ment of cardiovascular disease are required, together
with an improved nationwide surveillance system of
Table 3 Parameter estimates in the Poisson model
Parameter Estimate (standard error) 95% Confidence interval P-value
≥ 75 years (b2) 3.61(0.07) 3.48, 3.73 < 0.01
65-74 years (b3) 2.98 (0.07) 2.85, 3.12 < 0.01
50-64 years (b4) 2.34 (0.07) 2.21, 2.47 < 0.01
Female (b5) -1.39 (0.08) -1.54, -1.23 < 0.01
Female, ≥ 75 years (b6) 0.98 (0.08) 0.82, 1.13 < 0.01
Female, 65-74 years (b7) 0.63 (0.08) 0.46, 0.80 < 0.01
Female, 50-64 years (b8) 0.21 (0.08) 0.04, 0.37 0.01
Year (b1) 0.01 (0.01) -0.01, 0.04 0.24
Year*Female (b9) -0.0005 (0.01) -0.02, 0.02 0.95
Year* ≥ 75+ years (b10) -0.05 (0.01) -0.08, -0.02 < 0.01
Year*65-74 years (b11) -0.04 (0.02) -0.07, 0.00 0.02
Year*50-64 years (b12) -0.01 (0.01) -0.04, 0.02 0.34
Scale
† 5.96
Deviance = 1842.83, Pearson c
2 = 1810.59, degrees of freedom = 51, Akaike information criterion = 96.53, Bayesian information criterion = 124.60
† Scale parameter estimated by square root of Pearson’s c
2/degrees of freedom
Table 4 Estimated baseline log rates (year 2002) and time effects for eight groups
Gender*Age group Log (rate of hospitalization) Intercept Slope for fiscal year
Male, ≥ 75 years Log (count/population) = b0 + b2 b1 + b10 (-0.0329)
Male, 65-74 years b0 + b3 b1 + b11 (-0.0203)
Male, 50-64 years b0 + b4 b1 + b12 (0.0008)
Male, < 50 years b0 b1 (0.0149)
Female, ≥ 75 years b0 + b5 + b2 + b6 b1 + b9 + b10 (-0.0334)
Female, 65-74 years b0 + b5 + b3 + b7 b1 + b9 + b11 (-0.0208)
Female, 50-64 years b0 + b5 + b4 + b8 b1 + b9 + b12 (0.0003)
Female, < 50 years b0 + b5 b1 + b9 (0.0144)
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Page 8 of 10cardiovascular events. To more completely assess the
burden of heart disease, it is important not only to deter-
mine how many people are hospitalized as a result of it
or die from it, but also to monitor how many live with
heart disease and its impact on their quality of life.
Appendix
A.1. Final Poisson regression model
Log (count/population) = b0 + b1*Year + b2*I(≥ 75
years) + b3*I(65-74 years) + b4*I(50-64 years) +
b5*Female + b6*I(Female, ≥ 75 years) + b7*I(Female, 65-
74 years) + b8*I(Female, 50-64 years) + b9*Year*Female
+ b10*Year*I(≥ 75 years) + b11*Year*I(65-74 years) +
b12*Year* I(50-64 years), where Year = 0,...,7
Tables 3 and 4
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